- Home
- RNXT vs FAAS Comparison
RNXT vs FAAS Comparison
Compare RNXT & FAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- FAAS
- Stock Information
- Founded
- RNXT 2012
- FAAS 2021
- Country
- RNXT United States
- FAAS Indonesia
- Employees
- RNXT N/A
- FAAS N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- FAAS
- Sector
- RNXT Health Care
- FAAS
- Exchange
- RNXT Nasdaq
- FAAS NYSE
- Market Cap
- RNXT 44.6M
- FAAS 48.2M
- IPO Year
- RNXT 2021
- FAAS N/A
- Fundamental
- Price
- RNXT $1.30
- FAAS $0.46
- Analyst Decision
- RNXT Strong Buy
- FAAS
- Analyst Count
- RNXT 2
- FAAS 0
- Target Price
- RNXT $7.25
- FAAS N/A
- AVG Volume (30 Days)
- RNXT 141.1K
- FAAS 1.8M
- Earning Date
- RNXT 08-12-2025
- FAAS 01-01-0001
- Dividend Yield
- RNXT N/A
- FAAS N/A
- EPS Growth
- RNXT N/A
- FAAS N/A
- EPS
- RNXT N/A
- FAAS N/A
- Revenue
- RNXT $240,000.00
- FAAS $57,730,593.00
- Revenue This Year
- RNXT $3,186.05
- FAAS N/A
- Revenue Next Year
- RNXT $291.93
- FAAS N/A
- P/E Ratio
- RNXT N/A
- FAAS N/A
- Revenue Growth
- RNXT N/A
- FAAS 38.16
- 52 Week Low
- RNXT $0.75
- FAAS $0.16
- 52 Week High
- RNXT $1.69
- FAAS $5.85
- Technical
- Relative Strength Index (RSI)
- RNXT 48.98
- FAAS 41.58
- Support Level
- RNXT $1.27
- FAAS $0.43
- Resistance Level
- RNXT $1.38
- FAAS $0.60
- Average True Range (ATR)
- RNXT 0.06
- FAAS 0.06
- MACD
- RNXT -0.01
- FAAS -0.02
- Stochastic Oscillator
- RNXT 23.23
- FAAS 15.59
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About FAAS DIGIASIA CORP
DigiAsia Corp operates as a holding company. The majority of DigiAsia's operations are currently conducted through its majority-owned entities, controlled entities and corporate joint venture. It is among the first embedded fintech as a service (EFaaS) companies in Indonesia serving business-to-business-to-consumer (B2B2C) customers, such as large corporations and state-owned enterprises, as well as business-to-business (B2B) customers, such as micro, small and medium-sized enterprise (MSME) merchants, across various segments. It aims to be a fintech-enabling platform in Southeast Asia by accelerating financial inclusion through its licenses and technology stack and combining the benefits of technological innovation with traditional financial services.